Piperaquine
Sponsors
Universiteit Antwerpen, University of Oxford, Syamsudin Abdillah,Ph.D, Pharm D, Ifakara Health Institute
Conditions
HealthyInfectionsMalariaMalaria, VivaxMalaria,FalciparumUncomplicated MalariaUncomplicated Plasmodium Falciparum
Phase 1
Controlled Human Malaria Infection Transmission Model - Phase A
SuspendedNCT04280692
Start: 2022-08-22End: 2026-08-31Updated: 2024-05-23
In-vivo Transmission model in semi-immune adults
Active, not recruitingPACTR202312585218142
Start: 2024-01-09Target: 24Updated: 2026-01-27
A Clinical Study of Piperaquine, Pyronaridine, and Artesunate Administered in Combination in Healthy Adults
Not yet recruitingNCT07470424
Start: 2026-06-01End: 2027-08-01Target: 24Updated: 2026-03-13
Phase 2
Momordica Charantia and Dihydroartemisinin-piperaquined-primaquine for Uncomplicated Plasmodium Falciparum Malaria Patients in Southwest Sumba Regency
CompletedNCT05829187
Start: 2022-11-01End: 2022-12-31Updated: 2023-05-16
Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua
CompletedNCT06036030
Start: 2019-01-11End: 2019-04-16Updated: 2023-09-13